NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
March 25 2024 - 6:38PM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three and 12 months
ended December 31, 2023 after market close on Tuesday, March 26,
2024 and will hold an investment community conference call that day
beginning at 4:30 p.m. Eastern time.
Date/Time:
Tuesday, March 26, 4:30 p.m. ET / 1:30
p.m. PT
Pre-Registration:
Participants can pre-register for the
conference call here:
Callers who pre-register will be given a
conference passcode and unique PIN to gain immediate access to the
call and bypass the live operator. Participants may pre-register at
any time, including up to and after the call start time.
Dial In:
Those who choose not to pre-register can
access the live conference call by dialing the following and
requesting the NovaBay Pharmaceuticals call:
833-816-1121 from within the U.S.
412-317-1862 from outside the U.S.
The live webcast of the conference call also will be available
on the Events section of the Company website. A replay of the call
will be available beginning two hours after its completion through
April 16, 2024 by dialing 877-344-7529 from within the U.S.,
855-669-9658 from Canada or 412-317-0088 from outside the U.S., and
entering conference ID 1489846. The webcast will also be archived
here.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically
created and clinically proven eyecare, skincare and wound care
products. NovaBay’s leading product Avenova® Antimicrobial Lid
& Lash Solution is often prescribed by eyecare professionals
for blepharitis and dry-eye disease and is also available directly
to consumers through online distribution channels such as
Amazon.com. NovaBay also manufactures and sells effective, yet
gentle and non-irritating wound care products. The PhaseOne® brand
is distributed through commercial partners in the U.S. for
professional use only, and the NeutroPhase® brand is distributed in
China by China Pioneer Pharma Holdings, Limited. More information
about NovaBay is available here.
Socialize and Stay Informed on
NovaBay’s Progress Like us on Facebook Follow us on X
Connect with NovaBay on LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240325019136/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com Investor
Contact LHA Investor Relations Jody Cain 310-691-7100
jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024